The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) is a collaboration of researchers from UCLA, Charles Drew University of Medicine and Science, Friends ResearchInstitute, and the RAND Corporation working with the broader Los Angeles community toward a common goal: to enhance our collective understanding of HIV research and to promote early detection, as well as effective prevention and treatment programs for HIV. Funded by the National Institute of Mental Health, CHIPTS serves as a bridge among researchers, government, service providers, and people with HIV in responding to the changes in the HIV epidemic and in shaping sound public policy
The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) is a collaboration of researchers from UCLA, Charles Drew University of Medicine and Science, Friends ResearchInstitute, and the RAND Corporation working with the broader Los Angeles community toward a common goal: to enhance our collective understanding of HIV research and to promote early detection, as well as effective prevention and treatment programs for HIV. Funded by the National Institute of Mental Health, CHIPTS serves as a bridge among researchers, government, service providers, and people with HIV in responding to the changes in the HIV epidemic and in shaping sound public policy
SAPHIR is a year-long training program in comprehensive HIV prevention research in Latin America for U.S. medical students and residents. Each SAPHIR trainee is matched with mentors from UCLA and one of our collaborating international organizations in Lima, Peru , Rio de Janeiro, Brazil, or Porto Alegre, Brazil . Applications will be accepted on a rolling basis, with a priority deadline of February 4, 2022
Agenda for the upcoming HIV, Methamphetamine Use, and Pulmonary Hypertension: From Blue Skies to an Integrated Research conference on October 20, 2021, that shares the latest findings and current state of knowledge surrounding HIV, methamphetamine use, and pulmonary hypertension.
This policy brief describes how re-entry has been associated with increased, illness, mortality, and risky health behaviors. The brief highlights the process of community re-entry presenting a crucial opportunity to link individuals with needed health and social services. This brief looks to HIV, a pandemic predating COVID-19, in order to draw broader lessons for addressing the needs of incarcerated populations in the United States during re-entry.
CHIPTS is accepting Letters of Intent for novel seed grant proposals relevant to understanding the biology of HIV and substance use or substance use disorders (SUD). Examples of competitive research topics include studies that integrate behavioral factors (e.g., drug exposure levels, psychiatric symptoms, environmental exposures) that correspond with biological or clinical markers.
Oral Presentation by Laura Thomas, Director of Harm Reduction Policy, San Francisco AIDS Foundation that describe policies affecting the health and well-being of people who use drugs, examines the harm reduction policy landscape, and policy gaps and opportunities in California.
Oral presentation by Oni J. Blackstock (Health Justice) that addresses medical mistrust in Black Communities and describes the implications for COVID-19, HIV, Hepatitis, STIs and other conditions. The presentation provides an understanding of the racist policies and practices that have contributed to medical mistrust in the Black community and characterizes the relationship between medical mistrust and select health care outcomes.